IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CORTELLARO, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.528
NA - Nord America 2.610
AS - Asia 1.146
SA - Sud America 56
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 8.351
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.538
GB - Regno Unito 1.757
IT - Italia 683
CN - Cina 613
SE - Svezia 610
DE - Germania 544
UA - Ucraina 255
IN - India 145
KR - Corea 137
RU - Federazione Russa 133
IE - Irlanda 125
TR - Turchia 120
EU - Europa 117
FR - Francia 109
FI - Finlandia 89
NL - Olanda 76
CA - Canada 70
BE - Belgio 49
CO - Colombia 48
PL - Polonia 38
VN - Vietnam 34
HK - Hong Kong 29
DK - Danimarca 16
ID - Indonesia 16
GR - Grecia 14
SG - Singapore 14
JP - Giappone 9
IL - Israele 8
PK - Pakistan 8
SI - Slovenia 6
IR - Iran 5
RO - Romania 5
UZ - Uzbekistan 5
ES - Italia 4
BG - Bulgaria 3
CH - Svizzera 3
PT - Portogallo 3
AL - Albania 2
CL - Cile 2
ML - Mali 2
PE - Perù 2
VE - Venezuela 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CM - Camerun 1
CZ - Repubblica Ceca 1
EG - Egitto 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
TW - Taiwan 1
UY - Uruguay 1
Totale 8.466
Salva come PNG Salva come JPEG
Città #
Southend 1.631
Chandler 378
Jacksonville 214
Seattle 209
Beijing 182
Frankfurt am Main 176
Milan 161
Princeton 159
Wilmington 139
Dublin 123
Mountain View 112
Ann Arbor 98
Redmond 95
Nanjing 93
Woodbridge 87
Fairfield 85
Ashburn 84
Dearborn 74
Sakarya 66
Andover 58
Serra 57
Des Moines 56
Margão 56
Bengaluru 50
Toronto 50
Bogotá 48
Brussels 48
Somerville 48
Boardman 45
Nanchang 40
Houston 39
Cambridge 37
Warsaw 37
Shenyang 30
Jinan 29
Grafing 27
Hangzhou 27
Turin 27
Munich 23
Hanover 18
New York 18
Ottawa 18
Phoenix 18
Helsinki 17
Dong Ket 16
Medford 16
Auburn Hills 15
Berlin 15
Guangzhou 15
Tianjin 15
Athens 14
Changsha 14
Hebei 14
Rome 14
Verona 14
Bitonto 13
Redwood City 13
Hong Kong 12
Jiaxing 12
Kwai Chung 12
Roxbury 11
Taizhou 10
San Diego 9
Changchun 8
Como 8
Kiez 8
Kunming 8
Columbus 7
Padova 7
Saint Petersburg 7
Shanghai 7
Zhengzhou 7
Bari 6
Haikou 6
Los Angeles 6
Matsudo 6
Ningbo 6
Nürnberg 6
Palaiseau 6
Venezia 6
Bergamo 5
Bologna 5
Centro 5
Costa Mesa 5
Fuzhou 5
Genoa 5
Islamabad 5
Lanzhou 5
Postojna 5
Seoul 5
Wuhan 5
Hefei 4
London 4
Norwalk 4
San Jose 4
Trento 4
Atlanta 3
Casalecchio Di Reno 3
Cattolica 3
Central District 3
Totale 5.543
Salva come PNG Salva come JPEG
Nome #
Un caso di dolore osteo-muscolare non responsivo ai FANS 229
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 209
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction) : results of a prospective, multicenter study 206
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients : the baseline findings of the MIAMI study 203
Calo ponderale e leucocitosi: quale la causa? 188
Are pleiotropic effects of statins real? 185
Esordio tipico di emorragia cerebrale atipica 175
Danno d’organo subclinico in una popolazione sovrappeso/obesa a rischio cardiovascolare intermedio 164
null 159
Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease 158
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group 156
Anemia emolitica: malattia o epifenomeno? 156
The PLAT Study : a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients 151
Psicosi acuta ed epilessia: quale alterazione metabolica 149
Relationship between haemostatic variables and the progression of carotid atherosclerosis 147
Progetto innovativo per migliorare la qualità della prevenzione cardio-cerebrovascolare attraverso un modello di integrazione Ospedale-Territorio e la valutazione di parametri non compresi nella definizione del rischio intermedio – Progetto CAPRESS 144
Regression of severe atherosclerotic lesions after vitamin replacement in hyperhomocysteinemia with multiple heterozygous mutations 142
The ATROCAP Study: atorvastatin and the thrombogenicity of carotid atherosclerotic plaque 142
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study 140
Hemostatic variables and progression of common carotid intima-media thickness in patients with peripheral arterial disease 138
The PLAT Study : hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group Progetto Lombardo Atero-Trombosi (PLAT) Study Group 136
Subclinical disease (SD) in overweight and obese individuals at intermediate cardiovascular (CV) risk 135
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group 135
Un caso da manuale 132
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction): Results of a prospective, open-label, multicenter Study. 129
Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study 129
The MIAMI study (Markers of Inflammation and Atorvastatin effect in previous Myocardial Infarction): results of a prospective, open-label, multicenter study 128
Regression of severe atherosclerotic lesions after vitamin replacement in hyperhomocysteinemia with multiple heterozygous mutations 127
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group 127
E-Selettina e l’inibitore del fattore tissutale (TFPI) correlano con l’inspessimento medio-intimale carotideo (C-IMT) in pazienti con malattia ischemica coronarica in fase di stabilità clinica: risultati basali dello Studio MIAMI 126
Effetti di Atorvastatina su markers solubili aterosclerosi carotidea : Risultati dello Studio MIAMI 125
Target organ damage in an asymptomatic population at intermediate cardiovascular risk and adjunctive major risk factors : the cardiovascular prevention Sacco study (CAPRESS) 125
Atherosclerotic plaque as a therapeutic target. The ATROCAP Study (Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque). 124
A case of multiorgan atherosclerotic disease in patient affected by hyperhomocistinemia with multiple heterozigous muattions 121
Target organ damage in a population at intermediate cardiovascular risk, with adjunctive major risk factors : CArdiovascular PREvention Sacco Study (CAPRESS) 120
Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina : results from the Lescol Intervention Prevention Study (LIPS) 119
Soluble E-Selectin and tissue factor pathway inhibitor, but not C-reactive protein, correlate with carotid intima-media thickness (C-IMT) in stable coronary patients: the baseline data of the MIAMI Study 114
Inflammatory Markers and Carotid Intima Media Thickness (C-IMT) in Stable IHD Patients 112
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy) 110
E-selectin and TFPI are associated with carotid intima-media thickness in stable coronary patients : the baseline findings of the MIAMI Study 110
Cirrosi biliare primitiva ama negativa esordita con grave osteoporosi 108
Relazione tra variabili emostatiche e modificazioni dell'ispessimento intimale della carotide in pazienti con malattia ischemica periferica 105
Come migliorare la stratificazione del rischio intermedio 104
Inflammatory Markers and C-IMT in Patients with Previous Myocardial Infarction. The Atorvastatin Effect . MIAMI Study 101
Arteriosclerosi e suscettibilità d'organo 100
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease : the DAVID study 100
Effect of atorvastatin on coagulation and inflammatory variables in patients with bilateral carotid stenosis. 100
Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia 99
Dermatan sulphate in acute leukaemia 99
Markers of hemostatic system activation during thromboprophylaxis with recombinant hirudin in total hip replacement 98
Inibitori della COX-2: una promessa non mantenuta? Il parere dell'internista 97
Un insolito caso di malassorbimento 97
Valutazione della lesione d'organo subclinica nei soggetti a rischio cardiovascolare intermedio: un progetto di intehgrazione ospedale-territorio 96
Polineuropatia sensitivo-motoria acuta e febbre : un caso di panarterite 94
Markers infiammatori solubili ed evoluzione della placca aterosclerotica : effetto del trattamento con statina a dosi moderate in pazienti con cardiopatia ischemica stabile : studio MIAMI 94
Relation between hemostatic variables and changes of carotid intima-media thickness in PAD patients 94
Progetti regionali innovativi area cardiocerebrovascolare 90
Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukemia: a randomised, heparin-controlled pilot study 90
Esiste realmente l'effetto antinfiammatorio delle statine? 89
Flogosi granulomatosa polmonare in B-LLC trattata con fludarabina 87
Dai grandi trials alla pratica clinica: l’esempio delle statine 86
The regression between multiple inflammatory markers and C-IMT in normocholesterolemic stable IHD. The effect of moderate dose of atorvastatina (MIAMI study) 86
Antiatherosclerotic and antiatherothrombotic effects of statins 85
Switching statins : an appropriate guideline for clinical practice? 83
The antiatherothrombotic effects of Atorvastatin : the ATROCAP Study results 83
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia 83
Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment 82
Idarubicin in the therapy of acute myeloid leukemia : final analysis in 57 previously untreated patients 81
Placca o individuo a rischio? 78
Biomarkers ed evoluzione della placca 77
Progetto pilota di collaborazione tra medici di medicina generale e ospedale per migliorare la valutazione del rischio cardiovascolare in soggetti a rischio intermedio. 69
Does the metabolic syndrome predict subclinical atherosclerotic damage in an asymptomatic population at intermediate cardiovascular risk? 69
Fibrinolytic variables in atherosclerotic patients-comparison between patients with and without peripheral arterial-disease (PAD) 67
Fibrinolytic variables in prediction of atherothrombotic sequelae in patients with preexisting vascular ischaemic disease : the plat study 63
Inflammatory markers and C-IMT in patients with previous myocardial infarction. The atorvastatin effect. MIAMI Study 58
FVIII-C-VWF-AG, fibrinogen, PAI-1 and leukocytes are associated with ischemic events in vascular-disease patients : the plat study 43
null 4
Totale 8.964
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019605 0 0 0 0 0 109 157 34 82 131 51 41
2019/20201.236 139 41 63 76 69 135 146 87 122 184 138 36
2020/20211.153 15 98 130 18 78 69 80 33 161 51 350 70
2021/2022804 90 28 27 41 33 58 83 49 90 51 72 182
2022/20231.251 150 152 112 144 154 226 28 74 141 4 52 14
2023/2024479 35 58 60 78 201 47 0 0 0 0 0 0
Totale 8.964